Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
KALV | KalVista Pharmaceuticals, Inc. | Chief Scientific Officer | $1.2M | -$1.44M | -54.5% | May 17, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|